Avanos Medical (AVNS) Invested Capital (2016 - 2024)
Historic Invested Capital for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to $1.4 billion.
- Avanos Medical's Invested Capital fell 662.66% to $1.4 billion in Q3 2024 from the same period last year, while for Sep 2024 it was $1.4 billion, marking a year-over-year decrease of 662.66%. This contributed to the annual value of $1.4 billion for FY2023, which is 802.64% down from last year.
- Per Avanos Medical's latest filing, its Invested Capital stood at $1.4 billion for Q3 2024, which was down 662.66% from $1.4 billion recorded in Q2 2024.
- Over the past 5 years, Avanos Medical's Invested Capital peaked at $1.5 billion during Q3 2020, and registered a low of $1.4 billion during Q3 2024.
- Its 5-year average for Invested Capital is $1.5 billion, with a median of $1.5 billion in 2021.
- Its Invested Capital has fluctuated over the past 5 years, first tumbled by 854.78% in 2021, then soared by 834.64% in 2022.
- Avanos Medical's Invested Capital (Quarter) stood at $1.4 billion in 2020, then decreased by 2.88% to $1.4 billion in 2021, then increased by 8.35% to $1.5 billion in 2022, then dropped by 8.03% to $1.4 billion in 2023, then decreased by 0.96% to $1.4 billion in 2024.
- Its Invested Capital was $1.4 billion in Q3 2024, compared to $1.4 billion in Q2 2024 and $1.4 billion in Q1 2024.